Cargando…
Atypical Peripheral Blood Cell Morphology in COVID-19 (Sars-CoV-2) Patients from Mount Sinai Health System in New York City
INTRODUCTION Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Recent studies have suggested that COVID-19 positive patients present with leukopenia, lymphopenia, neutrophilia, thrombocytopen...
Autores principales: | Salib, Christian, Khattar, Pallavi, Cheng, Jinjun, Teruya-Feldstein, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330324/ http://dx.doi.org/10.1182/blood-2020-142581 |
Ejemplares similares
-
Report of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in Four Patients with Hematological Malignancies Treated at King Fahad Medical City, Riyadh, Saudi Arabia
por: Motabi, Ibraheem H, et al.
Publicado: (2016) -
Impact of Sars-CoV2 Infection on 491 Hematological Patients: The Ecovidehe Multicenter Study
por: De Ramón, Cristina, et al.
Publicado: (2020) -
CD28 Expression Distinguishes Plasma Cell Fate in Pediatric Patients Suffering from COVID-19/Kawasaki's Disease Vs MIS-C
por: Utley, Adam, et al.
Publicado: (2020) -
COVID-19 in Patients with Hematological Malignancies: High False Negative Rate with High Mortality
por: Niu, Alex, et al.
Publicado: (2020) -
COVID-19: B-Cell Depletion and Sepsis Related Changes in Bone Marrow and Spleen
por: Ihlow, Jana, et al.
Publicado: (2020)